HHMI - Howard Hughes Medical Institute

HHMI scientists have joined their colleagues around the world in working to understand and slow the spread of COVID-19. They’re developing diagnostic testing, understanding the virus’s basic biology, modeling the epidemiology, and developing potential therapies or vaccines.

HHMI announces the selection of 21 exceptional early career scientists as 2020 Hanna Gray Fellows to support diversity in biomedical research. The 2022 Hanna H. Gray Fellows Program competition will open later this year.

People taking cholesterol-lowering drugs may fare better than others if they catch the novel coronavirus. A new study hints at why: the virus relies on the fatty molecule to get past the cell’s protective membrane.

Julius, a professor at the University of California, San Francisco, will join HHMI’s Board of Trustees.

Lavizzo-Mourey, University of Pennsylvania professor and former president and CEO of the Robert Wood Johnson Foundation, will join HHMI’s Board of Trustees.

Like a computer, cells must process information from the outside world before they respond. Scientists have now developed a powerful new way to observe the internal discussions responsible for cellular decisions.

People who have recovered from coronavirus can make potent antibodies to SARS-CoV-2 that evolve in the months after infection. These antibodies may be evolving in response to residual viral antigen hidden in the gut.

The Royal Swedish Academy of Sciences announced today that HHMI Investigator Jennifer Doudna of University of California, Berkeley, and Emmanuelle Charpentier of the Max Planck Unit for the Science of Pathogens are the recipients of the 2020 Nobel Prize in Chemistry for the development of a method for genome editing.

The new Open Access to Publications policy, which will take effect on January 1, 2022, will require all HHMI laboratory heads to publish in a manner that makes their research articles freely available on the publication date under a Creative Commons Attribution License (CC BY).